0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Artificial Blood Substitute Market Report & Forecast 2021-2027
Published Date: October 2021
|
Report Code: QYRE-Auto-31R5313
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
China Artificial Blood Substitute Market Report Forecast 2021 2027

China Artificial Blood Substitute Market Report & Forecast 2021-2027

Code: QYRE-Auto-31R5313
Report
October 2021
91 Pages
QYResearch
Region: Global, China,
Description
Table of Content
Tables & Figures
China Artificial Blood Substitute Market, By Type, 2016-2021, 2022-2027 ($ Millions)
China Artificial Blood Substitute Market Segment Percentages, By Type, 2020 (%)
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
China Artificial Blood Substitute Market, By Application, 2016-2021, 2022-2027 ($ Millions)
China Artificial Blood Substitute Market Segment Percentages, By Application, 2020 (%)
Military
Civil
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Blood Substitute revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Artificial Blood Substitute revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
1 Introduction to Research & Analysis Reports
1.1 Artificial Blood Substitute Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Artificial Blood Substitute Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Artificial Blood Substitute Overall Market Size
2.1 China Artificial Blood Substitute Market Size: 2021 VS 2027
2.2 China Artificial Blood Substitute Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Blood Substitute Players in China Market
3.2 Top China Artificial Blood Substitute Companies Ranked by Revenue
3.3 China Artificial Blood Substitute Revenue by Companies
3.4 Top 3 and Top 5 Artificial Blood Substitute Companies in China Market, by Revenue in 2020
3.5 Companies Artificial Blood Substitute Product Type
3.6 Tier 1, Tier 2 and Tier 3 Artificial Blood Substitute Players in China Market
3.6.1 List of Tier 1 Artificial Blood Substitute Companies in China
3.6.2 List of Tier 2 and Tier 3 Artificial Blood Substitute Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Artificial Blood Substitute Market Size Markets, 2021 & 2027
4.1.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
4.1.3 Hemoglobin-based Oxygen Carrier (HBOC)
4.2 By Type - China Artificial Blood Substitute Revenue & Forecasts
4.2.1 By Type - China Artificial Blood Substitute Revenue, 2016-2021
4.2.2 By Type - China Artificial Blood Substitute Revenue, 2022-2027
4.2.3 By Type - China Artificial Blood Substitute Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Artificial Blood Substitute Market Size, 2021 & 2027
5.1.2 Military
5.1.3 Civil
5.2 By Application - China Artificial Blood Substitute Revenue & Forecasts
5.2.1 By Application - China Artificial Blood Substitute Revenue, 2016-2021
5.2.2 By Application - China Artificial Blood Substitute Revenue, 2022-2027
5.2.3 By Application - China Artificial Blood Substitute Revenue Market Share, 2016-2027
6 Artificial Blood Substitute Companies Profiles
6.1 Aurum Biosciences Ltd.
6.1.1 Aurum Biosciences Ltd. Company Details
6.1.2 Aurum Biosciences Ltd. Business Overview
6.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Introduction
6.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue in China Market (2016-2021)
6.1.5 Aurum Biosciences Ltd. Recent Developments
6.2 HEMARINA SA
6.2.1 HEMARINA SA Company Details
6.2.2 HEMARINA SA Business Overview
6.2.3 HEMARINA SA Artificial Blood Substitute Introduction
6.2.4 HEMARINA SA Artificial Blood Substitute Revenue in China Market (2016-2021)
6.2.5 HEMARINA SA Recent Developments
6.3 HbO2 Therapeutics
6.3.1 HbO2 Therapeutics Company Details
6.3.2 HbO2 Therapeutics Business Overview
6.3.3 HbO2 Therapeutics Artificial Blood Substitute Introduction
6.3.4 HbO2 Therapeutics Artificial Blood Substitute Revenue in China Market (2016-2021)
6.3.5 HbO2 Therapeutics Recent Developments
6.4 KaloCyte Inc.
6.4.1 KaloCyte Inc. Company Details
6.4.2 KaloCyte Inc. Business Overview
6.4.3 KaloCyte Inc. Artificial Blood Substitute Introduction
6.4.4 KaloCyte Inc. Artificial Blood Substitute Revenue in China Market (2016-2021)
6.4.5 KaloCyte Inc. Recent Developments
6.5 SpheriTech Ltd.
6.5.1 SpheriTech Ltd. Company Details
6.5.2 SpheriTech Ltd. Business Overview
6.5.3 SpheriTech Ltd. Artificial Blood Substitute Introduction
6.5.4 SpheriTech Ltd. Artificial Blood Substitute Revenue in China Market (2016-2021)
6.5.5 SpheriTech Ltd. Recent Developments
6.6 NuvOx Pharma
6.6.1 NuvOx Pharma Company Details
6.6.2 NuvOx Pharma Business Overview
6.6.3 NuvOx Pharma Artificial Blood Substitute Introduction
6.6.4 NuvOx Pharma Artificial Blood Substitute Revenue in China Market (2016-2021)
6.6.5 NuvOx Pharma Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
    Table 1. Artificial Blood Substitute Market Opportunities & Trends in China Market
    Table 2. Artificial Blood Substitute Market Drivers in China Market
    Table 3. Artificial Blood Substitute Market Restraints in China Market
    Table 4. Key Players of Artificial Blood Substitute in China Market
    Table 5. Top Artificial Blood Substitute Players in China Market, Ranking by Revenue (2019)
    Table 6. China Artificial Blood Substitute Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. China Artificial Blood Substitute Revenue Share by Companies, 2016-2021
    Table 8. Companies Artificial Blood Substitute Product Type
    Table 9. List of Tier 1 Artificial Blood Substitute Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Artificial Blood Substitute Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – China Artificial Blood Substitute Revenue, (US$, Mn), 2021 & 2027
    Table 12. By Type - China Artificial Blood Substitute Revenue (US$, Mn), 2016-2021
    Table 13. By Type - China Artificial Blood Substitute Revenue (US$, Mn), 2022-2027
    Table 14. By Application – China Artificial Blood Substitute Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - China Artificial Blood Substitute Revenue (US$, Mn), 2016-2021
    Table 16. By Application - China Artificial Blood Substitute Revenue (US$, Mn), 2022-2027
    Table 17. Aurum Biosciences Ltd. Company Details
    Table 18. Aurum Biosciences Ltd. Business Overview
    Table 19. Aurum Biosciences Ltd. Artificial Blood Substitute Product
    Table 20. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million)
    Table 21. Aurum Biosciences Ltd. Recent Developments
    Table 22. HEMARINA SA Company Details
    Table 23. HEMARINA SA Business Overview
    Table 24. HEMARINA SA Artificial Blood Substitute Product
    Table 25. HEMARINA SA Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million)
    Table 26. HEMARINA SA Recent Developments
    Table 27. HbO2 Therapeutics Company Details
    Table 28. HbO2 Therapeutics Business Overview
    Table 29. HbO2 Therapeutics Artificial Blood Substitute Product
    Table 30. HbO2 Therapeutics Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million)
    Table 31. HbO2 Therapeutics Recent Developments
    Table 32. KaloCyte Inc. Company Details
    Table 33. KaloCyte Inc. Business Overview
    Table 34. KaloCyte Inc. Artificial Blood Substitute Product
    Table 35. KaloCyte Inc. Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million)
    Table 36. KaloCyte Inc. Recent Developments
    Table 37. SpheriTech Ltd. Company Details
    Table 38. SpheriTech Ltd. Business Overview
    Table 39. SpheriTech Ltd. Artificial Blood Substitute Product
    Table 40. SpheriTech Ltd. Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million)
    Table 41. SpheriTech Ltd. Recent Developments
    Table 42. NuvOx Pharma Company Details
    Table 43. NuvOx Pharma Business Overview
    Table 44. NuvOx Pharma Artificial Blood Substitute Product
    Table 45. NuvOx Pharma Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million)
    Table 46. NuvOx Pharma Recent Developments
List of Figures
    Figure 1. Artificial Blood Substitute Segment by Type
    Figure 2. Artificial Blood Substitute Segment by Application
    Figure 3. China Artificial Blood Substitute Market Overview: 2020
    Figure 4. China Artificial Blood Substitute Market Size: 2021 VS 2027 (US$, Mn)
    Figure 5. China Artificial Blood Substitute Revenue, 2016-2027 (US$, Mn)
    Figure 6. The Top 3 and 5 Players Market Share by Artificial Blood Substitute Revenue in 2020
    Figure 7. By Type - China Artificial Blood Substitute Revenue Market Share, 2016-2027
    Figure 8. By Application - China Artificial Blood Substitute Revenue Market Share, 2016-2027
    Figure 9. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 10. HEMARINA SA Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 11. HbO2 Therapeutics Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 12. KaloCyte Inc. Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 13. SpheriTech Ltd. Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 14. NuvOx Pharma Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India

RELATED REPORTS

Global and China Membrane Bioreactor MBR Systems Market Insights Forecast to 2027
Global and China Membrane Bioreactor (MBR) Systems Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24N7565
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Oligonucleotide API Market Insights Forecast to 2027
Global and China Oligonucleotide API Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34J7553
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and Japan Prokaryotic Recombinant Protein Market Insights Forecast to 2027
Global and Japan Prokaryotic Recombinant Protein Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-20U7714
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Lentiviral Vector In Gene Therapy Market Insights Forecast to 2027
Global and China Lentiviral Vector In Gene Therapy Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-30V7563
Tue Nov 30 00:00:00 UTC 2021

Add to Cart